Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro

Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro

Opis bibliograficzny
Główni autorzy:	Papageorgiou, M, Lippitt, J, Nyambo, R, Cross, N, Hamdy, F, Eaton, C
Format:	Conference item
Wydane:	2005

Podobne zapisy

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
od: Cross, N, i wsp.
Wydane: (2007)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
od: Nyambo, R, i wsp.
Wydane: (2004)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
od: Nyambo, R, i wsp.
Wydane: (2004)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
od: Adeniji, O, i wsp.
Wydane: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
od: Adeniji, O, i wsp.
Wydane: (2008)

Regulation of ADAMTS expression in prostate cancer and stromal cells by androgen and TNF
od: Molokwu, C, i wsp.
Wydane: (2007)

Androgens target prohibitin to regulate proliferation of prostate cancer cells.
od: Gamble, S, i wsp.
Wydane: (2004)

EZH2 promotes proliferation and invasiveness of prostate cancer cells.
od: Bryant, R, i wsp.
Wydane: (2007)

Effects of NCAM on migration in bone marrow stromal cells (BMSCs) induced by IGF-1.
od: Hang, Yi Ting.
Wydane: (2011)

Growth factor regulation of proliferation and survival of multipotential stromal cells
od: Rodrigues, Melanie, i wsp.
Wydane: (2012)

OPG is a survival factor for breast- and prostate cancer cells in vitro
od: Holen, I, i wsp.
Wydane: (2002)

Imaging proteolysis in prostate cancer and stromal cells
od: Molokwu, C, i wsp.
Wydane: (2007)

EFFECTS OF BETA-MERCAPTOETHANOL AND ASCORBATE ON THE PROLIFERATION AND DIFFERENTIATION OF HUMAN BONE-MARROW STROMAL FIBROBLASTIC CELLS
od: Inui, K, i wsp.
Wydane: (1995)

SYMPOSIUM - MARROW STROMAL CELL-DIFFERENTIATION - COMMENT
od: Triffitt, J
Wydane: (1995)

Androgen regulates ADAMTS15 gene expression in prostate cancer cells.
od: Molokwu, C, i wsp.
Wydane: (2010)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
od: Holen, I, i wsp.
Wydane: (2002)

Measurement of the insulin-like growth factor (IGF)-axis does not enhance the specificity of PSA-based prostate cancer screening.
od: Oliver, SE, i wsp.
Wydane: (2002)

The survival effect of prolactin on PC3 prostate cancer cells.
od: Ruffion, A, i wsp.
Wydane: (2003)

Onset of heterogeneity in culture-expanded bone marrow stromal cells
od: Whitfield, Matthew J., i wsp.
Wydane: (2014)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
od: Hamdy, F
Wydane: (2005)

Anticancer imidazoacridinone C-1311 is effective in androgen-dependent and androgen-independent prostate cancer cells
od: Niemira, M, i wsp.
Wydane: (2020)

Qualitative and quantitative PSA mRNA detection in prostate cancer - A useful tool for the clinician?
od: Phillips, J, i wsp.
Wydane: (2007)

Regulation of ADAMTS15 by dihydrotestosterone in prostate cancer cells and identification of putative androgen response elements
od: Molokwu, C, i wsp.
Wydane: (2009)

EXPRESSION OF ALKALINE-PHOSPHATASE ACTIVITY IN INVITRO CULTURES OF MARROW STROMAL CELLS
od: Owen, M, i wsp.
Wydane: (1984)

In vitro effects of growth factors and dexamethasone on rat marrow stromal cells.
od: Locklin, R, i wsp.
Wydane: (1995)

Adhesion and growth of bone marrow stromal cells on modified alginate hydrogels.
od: Lawson, M, i wsp.
Wydane: (2004)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
od: Eaton, C, i wsp.
Wydane: (2004)

Glycosylation is an androgen-regulated process essential for prostate cancer cell viability.
od: Munkley, J, i wsp.
Wydane: (2016)

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.
od: Handle, F, i wsp.
Wydane: (2019)

Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
od: Holen, I, i wsp.
Wydane: (2002)

Mutations in Bone Marrow-Derived Stromal Stem Cells Unmask Latent Malignancy
od: Houghton, JeanMarie, i wsp.
Wydane: (2011)

An investigation into the cytotoxic effects of microbubbles and their constituents on osteosarcoma and bone marrow stromal cells
od: Polydorou, AE, i wsp.
Wydane: (2023)

Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo.
od: Pathak, S, i wsp.
Wydane: (2008)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
od: Törnblom, M, i wsp.
Wydane: (2001)

Survival and PSA relapse data after hypofiractionated radiotherapy for early stage prostate cancer
od: Law, A, i wsp.
Wydane: (2007)

In situ normoxia enhances survival and proliferation rate of human adipose tissue-derived stromal cells without increasing the risk of tumourigenesis
od: Choi, J.R., i wsp.
Wydane: (2015)

Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence.
od: Giwercman, Y, i wsp.
Wydane: (2004)

Characterization and potential roles of bone marrow-derived stromal cells in cancer development and metastasis
od: Kawai, Hotaka, i wsp.
Wydane: (2018)

Characterization and potential roles of bone marrow-derived stromal cells in cancer development and metastasis
od: Kawai, Hotaka, i wsp.
Wydane: (2018)

Expansion of human bone marrow-derived mesenchymal stromal cells with enhanced immunomodulatory properties
od: Neo, Shu H., i wsp.
Wydane: (2023)